KLAS Releases 2026 Patient Financing Services Report Examining Recourse vs. Nonrecourse Offerings

9 hours ago 9

Rommie Analytics

KLAS Releases 2026 Patient Financing Services Report Examining Recourse vs. Nonrecourse Offerings

What You Should Know: 

– KLAS Report: According to the newly released Patient Financing Services 2026 report by KLAS, the industry is undergoing a critical structural shift in how these third-party programs are modeled—and one startup is capitalizing on the transition better than anyone else.

– The Market Shift: Patient financing services are third-party solutions that give patients flexibility to pay their healthcare costs over time, simultaneously shifting long-term receivables and potential financial risk away from the healthcare organization.

– Recourse vs. Nonrecourse: The market is divided into two primary models. In recourse financing, the healthcare organization retains the financial risk if a patient defaults, but enjoys lower program fees and broader patient eligibility. In nonrecourse financing, the third-party firm assumes the full risk of patient nonpayment.

Understanding the Two Primary Models

Organizations typically choose between recourse and nonrecourse financing based on their risk appetite, financial goals, and operational capacity.

Recourse Financing

In this model, the healthcare organization retains the financial responsibility if a patient defaults; unpaid balances eventually shift back to the provider.

Key Advantage: Generally features lower program fees and less restrictive patient eligibility criteria.Primary Decision Factor: Chosen by organizations prioritizing a better ROI and broader patient access.

Nonrecourse Financing

The financing firm assumes the full risk of patient nonpayment, meaning the healthcare organization is not obligated to reimburse the firm if a patient defaults.

Key Advantage: Offers risk transfer and accounting finality, providing predictable cash flow.Primary Decision Factor: Favored by organizations seeking operational simplicity and those dissatisfied with prior recourse models.

Vendor Performance & Insights

PayZen (Score: 95.2): Recognized as the 2026 Best in KLAS winner, PayZen is praised for its nonrecourse model that delivers immediate cash flow, reduces bad debt, and offers flexible payment options. Clients consistently highlight PayZen’s reliable technology, transparent reporting, and strong multichannel patient engagement.ClearBalance Healthcare (Score: 93.4): This firm drives high satisfaction through a patient-centric recourse model that features multiple plan tiers, flexible repayment terms, and notably low recourse rates.iVitaFi (Score: 92.7): Highly regarded for its nonrecourse model, iVitaFi provides predictable cash flow while reducing the collection burden on internal staff. Clients report strong system integration, hands-on adoption support, and responsive account teams.Curae (Score: 88.7): Curae’s nonrecourse model is appreciated for eliminating risk and providing quick payments without creating long-term administrative burdens. While some clients cite high costs, highly satisfied respondents praise the firm’s attentive communication.CarePayment (Score: 86.6): Most clients using CarePayment’s recourse model are highly satisfied, highlighting the firm’s flexibility with patients and organizations, as well as its high-touch partnership.AccessOne (Score: 76.6): AccessOne has experienced declining satisfaction, with clients primarily citing turnover among leadership and account managers. This has led to inconsistent communication, a loss of institutional knowledge, and slower issue resolution.
Read Entire Article